Exp Clin Endocrinol Diabetes 2025; 133(03): 120-132
DOI: 10.1055/a-2502-8712
Article

Metrnl Ameliorates Ferroptosis in Model of Diabetic Foot Ulcer Through the Inhibition of Mitochondrial Damage via LKB1/AMPK Signaling

Xiangjian Meng
1   Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, China
2   Department of Endocrinology, Yijishan Hospital of Wannan Medical College, Wuhu, China
,
Zhichen PU
3   Drug Evaluation Center, Yijishan Hospital of Wannan Medical College, Wuhu, China
,
Junjun He
2   Department of Endocrinology, Yijishan Hospital of Wannan Medical College, Wuhu, China
,
Qin Li
2   Department of Endocrinology, Yijishan Hospital of Wannan Medical College, Wuhu, China
,
1   Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, China
› Author Affiliations
Supported by: Three New Projects of Yijishan Hospital, The First Affiliated Hospital of Wannan Medical Colleg Y2205
Supported by: Suzhou Science and Technology Plan Project SKJY2021082

Abstract

Objective

Diabetic foot ulcer (DFU) represents a severe complication of diabetes, mainly caused by peripheral vascular occlusion and infection, presenting significant clinical challenges in treatment and potentially resulting in gangrene, amputation, or even fatality. This study aimed to investigate the involvement and underlying mechanisms of Meteorin-like (Metrnl) in the pathogenic process of DFU.

Methods

Mice underwent diabetes induction by streptozotocin, while human umbilical vein endothelial cells (HUVECs) were exposed to 5.5, 10, 20 or 40 mM glucose. HUVECs were transfected with negative or Metrnl or si-nc or si-Metrnl plasmids via Lipofectamine 2000.

Results

The expression of Metrnl was down-regulated in both patients and the murine model of DFU. Elevated glucose levels diminished Metrnl through enhanced Metrnl ubiquitination. The suppression of Metrnl exacerbated foot ulcer in the mouse model of DFU. Metrnl alleviated oxidative stress and ferroptosis in the DFU model by inhibiting mitochondrial damage. Metrnl induced liver kinase B1 (LKB1)/AMP-activated protein kinase (AMPK) signaling in the DFU model. LKB1 attenuated the effects of Metrnl on oxidative stress and ferroptosis in the DFU model.

Discussion

  The data cumulatively demonstrate that Metrnl ameliorates ferroptosis in the DFU model by inhibiting mitochondrial damage via LKB1/AMPK signaling, suggesting that targeting Metrnl may emerge as a potential preventive approach against ferroptosis of DFU or other diabetes.



Publication History

Received: 21 May 2024

Accepted after revision: 09 December 2024

Article published online:
12 March 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Ge L, Zhao J, Tan M. et al. Multi-disciplinary diabetic limb salvage programme in octogenarians with diabetic foot ulcers is not futile: An observational study with historical controls. Int Wound J 2024; 21: e14801
  • 2 Hamad NA, Eltayeb LB, Yassin HM. Implication of low plasma arginine among patients with diabetic foot ulcer (DFU). Pak J Biol Sci 2024; 27: 46-51
  • 3 Kim J, Hurh K, Han S. et al. Association between antidepressants and the risk of diabetic foot ulcers and amputation in antidepressant-naïve type 2 diabetes mellitus patients: A nested case-control study. Diabetes Res Clin Pract 2024; 209: 111591
  • 4 Erel V, Nasirian A, Gu Y. et al. Development of cyclic pressure offloading insole for diabetic foot ulcer prevention. Int J Low Extrem Wounds. 2024 15347346241234825
  • 5 Eckert AJ, Zimny S, Altmeier M. et al. Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real-world data from the German/Austrian DPV registry. J Diabetes 2024; 16: e13531
  • 6 Lim JZ, Ng NS, Thomas C. Prevention and treatment of diabetic foot ulcers. J R Soc Med 2017; 110: 104-109
  • 7 Armstrong DG, Tan TW, Boulton AJM. et al. Diabetic foot ulcers: A Review. JAMA 2023; 330: 62-75
  • 8 Li J, Jiang C, Xia J. The role of programmed cell death in diabetic foot ulcers. Int Wound J 2023; 21: e14399
  • 9 Chen J, Li X, Liu H. et al. Bone marrow stromal cell-derived exosomal circular RNA improves diabetic foot ulcer wound healing by activating the nuclear factor erythroid 2-related factor 2 pathway and inhibiting ferroptosis. Diabet Med 2023; 40: e15031
  • 10 Wang X, Dai S, Zheng W. et al. Identification and verification of ferroptosis-related genes in diabetic foot using bioinformatics analysis. Int Wound J 2023; 20: 3191-3203
  • 11 Wang X, Jiang G, Zong J. et al. Revealing the novel ferroptosis-related therapeutic targets for diabetic foot ulcer based on the machine learning. Front Genet 2022; 13: 944425
  • 12 Haba D, Nakagami G, Minematsu T. et al. Low-frequency vibration promotes AMPK-mediated glucose uptake in 3T3-L1 adipocytes. Heliyon 2021; 7: e07897
  • 13 Huang H, Wang L, Qian F. et al. Liraglutide via activation of AMP-activated protein kinase-hypoxia inducible factor-1α-heme oxygenase-1 signaling promotes wound healing by preventing endothelial dysfunction in diabetic mice. Front Physiol 2021; 12: 660263
  • 14 Liu H, Wang Q, Shi G. et al. Emodin ameliorates renal damage and podocyte injury in a rat model of diabetic nephropathy via regulating AMPK/mTOR-mediated autophagy signaling pathway. Diabetes Metab Syndr Obes 2021; 14: 1253-1266
  • 15 Lin JT, Chen HM, Chiu CH. et al. AMP-activated protein kinase activators in diabetic ulcers: From animal studies to Phase II drugs under investigation. Expert Opin Investig Drugs 2014; 23: 1253-1265
  • 16 Koh HJ, Brandauer J, Goodyear LJ. LKB1 and AMPK and the regulation of skeletal muscle metabolism. Curr Opin Clin Nutr Metab Care 2008; 11: 227-232
  • 17 Lee J, Tsogbadrakh B, Yang S. et al. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection. Biochem Biophys Res Commun 2021; 534: 1040-1046
  • 18 Li A, Yi B, Han H. et al. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway. Autophagy 2022; 18: 877-890
  • 19 Yang P, Lu J, Zhang P. et al. Comprehensive analysis of prognosis and immune landscapes based on lipid-metabolism- and ferroptosis-associated signature in uterine corpus endometrial carcinoma. Diagnostics (Basel) 2023; 13: 870
  • 20 Guo Z, Tuo H, Tang N. et al. Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice. Int J Biol Sci 2022; 18: 826-840
  • 21 Alizadeh H. Meteorin-like protein (Metrnl): A metabolic syndrome biomarker and an exercise mediator. Cytokine 2022; 157: 155952
  • 22 Li Z, Gao Z, Sun T. et al. Meteorin-like/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: A comprehensive review of preclinical and clinical studies. Front Immunol 2023; 14: 1098570
  • 23 Jung TW, Lee SH, Kim HC. et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice. Exp Mol Med 2018; 50: 1-11
  • 24 Alizadeh H. Myokine-mediated exercise effects: The role of myokine meteorin-like hormone (Metrnl). Growth Factors 2021; 39: 71-78
  • 25 Zhang W, Liu Y, Zhou J. et al. Chicoric acid advanced PAQR3 ubiquitination to ameliorate ferroptosis in diabetes nephropathy through the relieving of the interaction between PAQR3 and P110α pathway. Clin Exp Hypertens 2024; 46: 2326021
  • 26 Pu Z, Han C, Zhang W. et al. Systematic understanding of the mechanism and effects of Arctigenin attenuates inflammation in dextran sulfate sodium-induced acute colitis through suppression of NLRP3 inflammasome by SIRT1. Am J Transl Res 2019; 11: 3992-4009
  • 27 Zhang W, Wang W, Xu M. et al. GPR43 regulation of mitochondrial damage to alleviate inflammatory reaction in sepsis. Aging (Albany NY) 2021; 13: 22588-22610
  • 28 Xu W, Che Y, Zhang Q. et al. Apaf-1 Pyroptosome senses mitochondrial permeability transition. Cell Metab 2021; 33: 424-436 e410
  • 29 Periasamy M, Muthukumar V, Venkatramani H. et al. Reconstruction of plantar forefoot in diabetic foot ulcers with microvascular tissue transfer using tunneled pedicle with dorsal anastomosis. J Plast Reconstr Aesthet Surg 2024; 91: 3-5
  • 30 Pang N, Laiva AL, Sulaiman NZ. et al. Dual glyoxalase-1 and β-klotho gene-activated scaffold reduces methylglyoxal and reprograms diabetic adipose-derived stem cells: Prospects in improved wound healing. Pharmaceutics 2024; 16: 265
  • 31 Wang K, Wang Y, Shi W. et al. Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA). Diabetes Metab Res Rev 2024; 40: e3776
  • 32 Lavery LA, Suludere MA, Ryan E. et al. The infected diabetic foot: Analysis of diabetic and non-diabetic foot infections. Wound Repair Regen 2024; 32: 360-365
  • 33 Suludere MA, Öz OK, Rogers LC. et al. MRSA infection, re-infection and clinical outcomes in diabetic foot infections. Wound Repair Regen 2024; 32: 377-383
  • 34 Shiraishi M, Lee H, Kanayama K. et al. Appropriateness of artificial intelligence chatbots in diabetic foot ulcer management. Int J Low Extrem Wounds. 2024 15347346241236811
  • 35 Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci 2018; 1411: 153-165
  • 36 Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376: 2367-2375
  • 37 Li Y, Cai Z, Ma W. et al. A DNA tetrahedron-based ferroptosis-suppressing nanoparticle: Superior delivery of curcumin and alleviation of diabetic osteoporosis. Bone Res 2024; 12: 14
  • 38 Liu Q, Liu CQ, Yi WZ. et al. Ferroptosis contributes to microvascular dysfunction in diabetic retinopathy. Am J Pathol 2024; 194: 1078-1089
  • 39 Wang R, Rao S, Zhong Z. et al. Emerging role of ferroptosis in diabetic retinopathy: A review. J Drug Target. 2024 32. 393-403
  • 40 Lyu X, Zhang TT, Ye Z. et al. Astragaloside IV mitigated diabetic nephropathy by restructuring intestinal microflora and ferroptosis. Mol Nutr Food Res. 2024 68. e2300734
  • 41 Zhang Z, Zheng Y, Chen N. et al. San Huang Xiao Yan recipe modulates the HMGB1-mediated abnormal inflammatory microenvironment and ameliorates diabetic foot by activating the AMPK/Nrf2 signalling pathway. Phytomedicine 2023; 118: 154931
  • 42 Yan L, Xu X, Fan Y. et al. Tangshen decoction enhances podocytes autophagy to relieve diabetic nephropathy through modulation of p-AMPK/p-ULK1 signaling. Evid Based Complement Alternat Med 2022; 2022: 3110854
  • 43 Szrejder M, Rachubik P, Rogacka D. et al. Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions. Biochim Biophys Acta Mol Basis Dis 2020; 1866: 165610
  • 44 Lu QB, Ding Y, Liu Y. et al. Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy. J Adv Res 2023; 51: 161-179
  • 45 Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression. Nat Rev Cancer 2009; 9: 563-575
  • 46 Wang QY, Tong AH, Pan YY. et al. The effect of cassia seed extract on the regulation of the LKB1-AMPK-GLUT4 signaling pathway in the skeletal muscle of diabetic rats to improve the insulin sensitivity of the skeletal muscle. Diabetol Metab Syndr 2019; 11: 108
  • 47 Paunovic V, Peric S, Vukovic I. et al. Downregulation of LKB1/AMPK signaling in blood mononuclear cells is associated with the severity of Guillain-Barre syndrome. Cells 2022; 11: 2897
  • 48 Xie L, Yuan Y, Xu S. et al. Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex. Cell Rep 2022; 41: 111498
  • 49 Xu XH, Hu Q, Zhou LS. et al. Berberine inhibits gluconeogenesis in skeletal muscles and adipose tissues in streptozotocin-induced diabetic rats via LKB1-AMPK-TORC2 signaling pathway. Curr Med Sci 2020; 40: 530-538